Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022.
I · Intervention 중재 / 시술
curative resection between 2007 and 2022
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three). [CONCLUSIONS] The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.
[PURPOSE] Spread through air spaces (STAS) is a poor prognostic factor for lung adenocarcinoma, particularly in patients undergoing limited resection, and its accurate prediction can improve the patie
APA
Kubouchi Y, Wada T, et al. (2026). Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.. Surgery today, 56(2), 133-143. https://doi.org/10.1007/s00595-025-03119-6
MLA
Kubouchi Y, et al.. "Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.." Surgery today, vol. 56, no. 2, 2026, pp. 133-143.
PMID
40839175 ↗
Abstract 한글 요약
[PURPOSE] Spread through air spaces (STAS) is a poor prognostic factor for lung adenocarcinoma, particularly in patients undergoing limited resection, and its accurate prediction can improve the patient outcomes. This study evaluated the impact of STAS on the surgical outcomes and predictive factors.
[METHODS] We analyzed 511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022. STAS was assessed histologically, and logistic regression was used to identify the predictors. The recurrence-free and overall survival rates were also evaluated.
[RESULTS] Among the patients, 27.8% had STAS with significantly poor 5-year recurrence-free survival (65.6% vs. 88.5% in STAS-positive vs.-negative cases, respectively), particularly in patients treated with sublobar resection. STAS was an independent, poor prognostic factor for the recurrence-free survival in the sublobar group but not in the lobectomy group. Elevated serum carcinoembryonic antigen (≥ 5.8 ng/mL), consolidation tumor ratio (≥ 0.9), and SUVmax (≥ 2.3) were independent predictors. STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three).
[CONCLUSIONS] The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.
[METHODS] We analyzed 511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022. STAS was assessed histologically, and logistic regression was used to identify the predictors. The recurrence-free and overall survival rates were also evaluated.
[RESULTS] Among the patients, 27.8% had STAS with significantly poor 5-year recurrence-free survival (65.6% vs. 88.5% in STAS-positive vs.-negative cases, respectively), particularly in patients treated with sublobar resection. STAS was an independent, poor prognostic factor for the recurrence-free survival in the sublobar group but not in the lobectomy group. Elevated serum carcinoembryonic antigen (≥ 5.8 ng/mL), consolidation tumor ratio (≥ 0.9), and SUVmax (≥ 2.3) were independent predictors. STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three).
[CONCLUSIONS] The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.